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ABSTRACT
Small-cell neuroendocrine carcinoma is a well-known aggressive neoplasia, 
which is usually associated with a poor prognosis. The lung is the most 
common primary site, but other organs may be involved, especially those of 
the digestive tract. The authors report the case of a 71-year-old Caucasian, 
male patient who was admitted because of congestive heart failure and loss of 
vision accompanied by right proptosis. Skull and sinuses computed tomography 
showed a tumoral mass involving the posterior region of the right eye, local 
bones, and paranasal sinuses. Because of severe hemodynamic instability, 
the patient died and no diagnostic investigation could be performed. Autopsy 
findings revealed small-cell neuroendocrine carcinoma of the esophagus and 
metastases to the posterior region of the right ocular globe, which affected 
the sinuses, the muscles of the ocular region, the orbit bones, the skull, the 
meninges and the brain, plus the liver, adrenal glands, and the pericardium. 
This case called the author’s attention to the extent of the metastatic disease 
in a patient who was firstly interpreted as presenting solely with congestive 
heart failure. The autopsy findings substantially aid the understanding of the 
immediate cause of death.
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INTRODUCTION
Small cell carcinoma (SCC) is a poor 
differentiated neuroendocrine carcinoma, which 
frequently involves the lung. However, its extra 
pulmonary origin represents 2.5-5.9% of all cases, 
represented by gastrointestinal (GI) and genitourinary 
systems, plus skin and thymus involvement.1-6. 
Among the GI viscera, the esophagus is the most 
commonly involved, although this histological tumor 
type represents only 0.4-3.1% of all esophageal 
neoplasms.1
Besides environmental factors, genetic 
alterations have a marked role in the pathophysiology 
of this tumor,7 independently of the primary site. 
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He also complained of vision loss for 2 
months accompanied by protrusion of the right eye 
globe. The ophthalmologic examination in the right 
eye revealed marked corneal deepithelization and 
edema, ocular protrusion, the absence of photomotor 
and consensual reflexes, and low visual acuity. The 
left eye was normal. Brain computed tomography 
and cranial magnetic resonance imaging (MRI) 
confirmed the presence of a neoplastic lesion 
infiltrating the paranasal sinuses and the frontal 
encephalic lobe (Figure 1). A tumoral biopsy was 
scheduled, but the patient died before the procedure 
could be done because of a refractory cardiogenic 
shock.
Autopsy findings included marked 
cardiomegaly with four-chamber dilation; the 
interventricular septum measured 18 mm, and 
the ventricular wall (posterior, anterior, and 
lateral) measured 15 mm. Radiological findings 
were confirmed at autopsy as a metastatic lesion 
most probably from an epithelial neoplasm of the 
esophagus. A 2 cm wide ulcerated lesion was found 
in the middle third and other lesion with a vegetating 
appearance measuring 1 cm in the upper third of 
the esophagus (Figure 2) The tumor infiltrated 
the submucosa, muscular (Figure 3 and 4A), and 
adventitia layers and adhered to the paraesophageal 
structures mainly at the esophageal-ulcerated 
lesion.
The histological examination showed a small-
cell neuroendocrine carcinoma of the esophagus, 
since AE1/AE3 positive and synaptophysin 
(Figure 4B) were positive.
Among the environmental factors, smoking and 
alcohol consumption are the main components.2,6,8 
Men are 1.3-3.2 times more affected than women 
mainly in the fifth or sixth decade of life. The 
initial symptoms are usually unremarkable, and 
even the clinical features of advanced disease 
are non-specific, like weight loss and instability of 
previous chronic diseases. Local symptoms, such 
as dysphagia and retrosternal pain, are associated 
with esophageal wall infiltration or occlusion of the 
esophageal lumen, which are associated with the 
worse prognosis in this setting.1,6,8-10
Pathological characteristics of SCC are the 
same, regardless of the primary site. The neoplastic 
cells are small, polymorphic, with scanty cytoplasm, 
and hyperchromatic nuclei, and they present a 
trabecular growth.2,3,8,9,11 The positivity for specific 
epithelial markers, such as epithelial membrane 
antigen (EMA), clonal cytokeratin (AE1/AE3), and 
cytokeratin 8 (CK8) identify these cells as being of 
epithelial origin.2,9,11 The neuroendocrine lineage is 
identified by other markers, such as neuron-specific 
enolase (NSE), synaptophysin (SyN), chromogranin 
A (CgA), and a neural cell adhesion molecule 
(CD56). About 36% of the esophageal SCC show 
histological heterogeneity, presenting endocrine 
and squamous lineages within the same tumor.9,11
CASE REPORT
A 71-year-old Caucasian male patient sought 
medical care complaining of a 4-month history of 
exertion dyspnea and edema of the lower limbs. 
His past medical history included hypertension 
and congestive heart failure, and although he 
had been abstinent for 1 year, he had previously 
smoked 75 packs/year. On physical examination 
he was hypotensive and cyanotic; his pulse was 
arrhythmic; he had edema of the lower limbs; he had 
bulging jugular veins when in the supine position; 
there were rales in the lower two-thirds of both 
lungs; and tender hepatomegaly was present. The 
electrocardiogram showed atrial fibrillation, and the 
echodopplercardiogram estimated the left ventricle 
ejection fraction of 63% (Teicholz), eccentric left 
ventricular hypertrophy, marked mitral insufficiency, 
and a left atrium of 85 mm. Pulmonary systolic 
pressure was estimated at 62 mmHg with marked 
tricuspid valve insufficiency. There were no valvular 
morphological abnormalities. He was hospitalized 
with the diagnosis of hypertensive cardiomyopathy 
and cor pulmonale.
Figure 1 – Cranial MRI showing the retroocular 
metastatic lesion.
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Metastatic involvement was found in the 
paranasal sinuses, the muscles around the right 
eye, the orbital bones (Figure 5), the meninges, the 
right frontal lobe, the liver, the adrenal glands, and 
the pericardium.
DISCUSSION
In 1952, the Pathology Institute of Belfast 
(Northern Ireland) first reported two cases of this 
neoplasia among 9,000 autopsies.1,12 Since then, 
around 350 cases of esophageal SCC have been 
published, showing its aggressive behavior and the 
challenging diagnosis in the great majority of cases, 
revealing the difficulty in establishing the best 
therapeutic option.1,9
In our case, diagnosis was missed due to 
the absence of specific symptoms, according to the 
literature.1-16 It is most likely that interleukins 1 and 
Figure 2 – Gross view of the esophagus showing a 
vegetating pattern lesion (A) and an ulcerated lesion 
(B) at the proximal and middle thirds, respectively.
Figure 3 – Photomicrography of the esophagus showing ulcerated lesions (arrows) with inflammatory 
infiltrate (arrowhead) involving the submucosa and muscular layers (HE, 40X).
Figure 4 – Photomicrography of the esophageal ulcerated lesion showing in A - Neoplastic cells with 
hyperchromatic nuclei, “salt-and-pepper” chromatin and scant cytoplasm. (HE, 400X), and in B - positivity for 
synaptophysin,(400X).
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advanced metastatic disease to well-known sites 
such as the liver and bones, but, in contrast to 
the majority of cases, the lungs were not involved. 
Surprisingly, metastases were found in previously 
unreported sites for this tumor, namely: the frontal 
lobe, the meninges, the skull, the paranasal sinuses, 
the eye and adjacent structures, the adrenal glands, 
and the pericardium.1,5,6,8,14,15
This neoplasia presents an overall survival 
rate that ranges between 3.1 and 7.5 months after 
the diagnosis.1,2,8,9 Metastatic disease at diagnosis 
is found in 31-90% of the cases.6
The World Health Organization classifies all 
the neuroendocrine neoplasms in three categories, 
according to their morphology, independently of 
the primary site; for example, well-differentiated 
neuroendocrine tumors with low malignant potential, 
well-differentiated neuroendocrine carcinoma 
(which are more aggressive with metastatic 
potential) and poorly-differentiated neuroendocrine 
carcinomas (which are high grade malignancies 
with poor prognosis).7
The anatomopathological and immuno-
histochemical criteria for the diagnosis of SCC 
are the same regardless of the primary site, but 
for the GI tract, the immunohistochemical markers 
CK8, SyN, NSE, and CD56 show more than 90% 
accuracy.3,8,9,11 In our case, only SyN and AE1/AE3 
were tested; therefore, we could not differentiate 
pure- or mixed-cell lineages in the tumor.
CONCLUSION
Small-cell neuroendocrine carcinoma is 
an aggressive neoplasm with poor prognosis, 
6, as well as the tumoral necrosis factor,16 may have 
contributed to the severe hemodynamic instability of 
the patient, which prevented any further diagnostic 
approach.
Neuroendocrine carcinomas with retroocular 
metastasis are scarce in the literature. Among the 
patients with this diagnosis, the main described 
symptoms are: diplopia (48%), local pain (42%), 
and loss of vision (30%). The signs at presentation 
are: proptosis (63%), strabismus (62%), and loss of 
vision (30%).15 Except for the pain, the patient of the 
case reported herein presented the main described 
signs and symptoms.
However, our patient did not present 
signs of carcinoid syndrome or paraneoplastic 
manifestations, since the latter is represented 
by three reports of esophageal SCC presenting 
sensory and motor neuropathy, inappropriate 
antidiuretic hormone secretion syndrome, and 
hypercalcemia.1,5,10,13 We did not attribute the heart 
failure to a possible carcinoid syndrome in our 
patient, since other manifestations of this syndrome 
were lacking, such as flushing, diarrhea, or 
bronchospasm. The carcinoid heart is characterized 
by an endocardial fibrous deposition, mainly at the 
outflow of the right cardiac chambers accompanied 
by valvular morphological derangement and 
dysfunction.17
On gross examination, esophageal SCC 
may present as infiltrating, polypoid, or ulcerated 
lesions10 mainly localized in the middle or lower third 
of the organ.1,6,8 The case reported herein presented 
an ulcerating lesion on the middle third, and another 
polypoid in the upper third, which is the site in 4–6% 
of all described esophageal SCCs.4,8,14 The tumor in 
this topography usually does not cause dysphagia. 
This patient already presented, at admission, an 
Figure 5 – A - Gross view of the retroocular mass involving the orbit muscles. B - Photomicrography of the 
retroocular mass showing neoplastic cells with the same pattern as the esophageal lesion (HE, 400X).
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regardless the primary site. Its rarity and late clinical 
manifestation, mostly represented by metastatic 
disease or systemic symptoms delay the diagnosis 
and treatment.
In our case, the diagnosis wasn’t totally 
established in life due to the unusual retro-ocular 
metastatic presentation. Inflammatory factors 
related to the tumor probably aggravated the heart 
failure.
This case demonstrates the importance of 
the autopsy for didactic and diagnostic purposes.
REFERENCES
1. Wang SY, Mao WM, Du XH, Xu YP, Zhang SZ. The 2002 
AJCC TNM classification is a better predictor of primary 
small cell esophageal carcinoma outcome than the VALSG 
staging system. Chin J Cancer. 2013;32:342-52.
2. Henry MACA, Lerco MM, Oliveira WK, et al. Carcinoma de 
pequenas células do esôfago: estudo clínico patológico 
de dois casos. ABCD Arq Bras Cir Dig. 2008;21:38-
40. Portuguese. http://dx.doi.org/10.1590/S0102-
67202008000100008
3. Yun JP, Zhang MF, Hou JH, et al. Primary small cell 
carcinoma of the esophagus: clinicopathological and 
immunohistochemical features of 21 cases. BMC Cancer. 
2007;7:38. http://dx.doi.org/10.1186/1471-2407-7-38
4. Casas F, Ferrer F, Farrús B, Casals J, Biete A. Primary 
small cell carcinoma of the esophagus: a review of the 




5. Rekhtman N. Neuroendocrine tumors of the lung: an update. 
Arch Pathol Lab Med. 2010;134:1628-38.
6. Vos B, Rozema T, Miller RC, et al. Small cell carcinoma of 
the esophagus: a multicentre Rare Cancer Network study. 
Dis Esophagus. 2011;24:258-64. http://dx.doi.org/10.1111/
j.1442-2050.2010.01133.x
Conflict of interest: None
Submitted on: 10th December 2013 
Accepted on: 15th March 2013
Correspondence: Mariana Bellaguarda de Castro Sepulvida 
Rua Espírito Santo, 1136 – Cerâmica – São Caetano do Sul – São Paulo/SP – Brazil 
CEP: 09530-701 – Phone: +55 (19) 99341-5399 
E-mail: mbellaguardasepulvida@yahoo.com.br
